TABLE 2

Physiological and imaging outcome measures before and after treatment

Pre-treatmentPost-treatmentWithin-subject absolute changeWithin-subject relative change %
XeMRI outcomes %  
 VDP (linear binning)6.8±3.83.8±2.7−3.0 (−4.9–−1.1)*−42.1 (−52.2–−31.9)*
 VDP (k-means)10.4±4.56.7±4.1−3.8 (−5.9–−1.7)*−34.6 (−49.3–−19.9)*
MBW outcomes (seated)  
 LCI15.2±2.413.7±2.4−1.5 (−2.4–−0.5)*−9.1 (−15.5–−2.6)*
 FRC L2.3±0.72.3±0.70.0 (−0.6–0.6)−2.8 (−61.1–57.4)
 CEV L35.6±15.331.6±14.1−4.1 (−6.7–−1.5)*−10.7 (−16.2–−5.2)*
 Sacin L−10.60±0.380.45±0.24−0.16 (−0.32–0.01)−15.4 (−36.2–5.3)
 Scond L−10.15±0.070.15±0.060.00 (−0.05–0.04)13.2 (−13.2–39.6)
MBW outcomes (supine)  
 LCI15.4±2.514.9±2.5−0.5 (−1.5–0.5)−2.7 (−9.6–4.2)
 FRC L2.1±0.62.0±0.6−0.2 (−0.8–0.3)−1.0 (−23.0–30.7)
 CEV L33.1±13.829.9±14.2−3.2 (−5.4–−1.0)*−10.2 (−16.2–−4.2)*
 Sacin L−10.61±0.450.44±0.21−0.16 (−0.32–0.01)−15.4 (−36.2–5.3)
 Scond L−10.18±0.090.19±0.070.00 (−0.05–0.04)13.2 (−13.2–39.6)
Spirometry and plethysmography outcomes  
 FEV1 % pred63.0±13.980.3±14.617.4 (12.7–22.1)*29.8 (21.1–38.5)*
 RV/TLC37.6±9.630.3±4.6−7.8 (−11.6–−4.0)*−17.9 (−25.2–−10.6)*
 FRC L2.5±0.72.4±0.6−0.1 (−0.2–0.0)*−4.1 (−9.1–1.0)
Clinical score outcome  
 Likert wellness score 1–10, median (IQR)7 (5–7)9 (7–10)2.0 (0.6–3.4)*39.1 (14.5–63.7)*

Data are presented as mean±sd or mean (95% CI), unless otherwise stated. XeMRI: magnetic resonance imaging using hyperpolarised 129Xe gas; VDP: ventilation defect per cent; MBW: multiple-breath washout; LCI: lung clearance index; FRC: functional residual capacity; CEV: cumulative expired volume; Sacin: acinar lung zone ventilation inhomogeneity; Scond: conductive lung zone ventilation inhomogeneity; FEV1: forced expiratory volume in 1 s; RV: residual volume; TLC: total lung capacity; IQR: interquartile range. *: p<0.05.